Benzalkonium chloride + Hypromellose (Benzalkonii chloridum + Hypromellosum)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Ophthalmic products

Rehydrates

Included in the formulation
  • Lacrisifi
    drops d / eye 
    SIIFI SpA     Italy
    • АТХ:

    S.01.X.A   Other drugs for the treatment of eye diseases

    S.01.X.A.20   Artificial tears and other indifferent drugs

    Pharmacodynamics:

    Combined drug.

    Benzalkonium chloride

    Has bactericidal action against yeast fungi and Gram-positive bacteria.

    Hypromellose

    The keratoprotector has a high viscosity, which increases the contact time of the solution with the cornea. Has a refractive index similar to the natural tear fluid.

    Stabilizes, restores and reproduces the optical characteristics of the tear film. Extends the effect of eye drops, while protecting the cornea from their irritating effect.

    Pharmacokinetics:

    The drug for topical application does not have a systemic effect on the body.

    Indications:

    It is used to treat the syndrome of "dry eye", lagophthalmus, trophic corneal ulcers, microdefects of the corneal epithelium, keratosis, thermal burns of the conjunctiva. Used for diagnostic procedures in ophthalmology; when the eyes are irritated with eye drops, dust, smoke, salt water, sun and wind.

    ICD-10

    VII.H00-H06.H04.1   Other diseases of the lacrimal gland

    VII.H15-H22.H16.0   Corneal ulcer

    VII.H15-H22.H18.1   Bullous Keratopathy

    XIX.T20-T32.T26   Thermal and chemical burns, limited to the area of ​​the eye and its adnexa

    XXI.Z40-Z54.Z51.4   Preparatory procedures for subsequent treatment, not elsewhere classified

    Contraindications:Acute inflammatory diseases of the anterior chamber of the eye, individual intolerance, children under 3 years old.
    Carefully:

    Chemical burns of the cornea and conjunctiva, hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category B. It is used during pregnancy and lactation.

    Dosing and Administration:

    Instillations in the conjunctival sac 1-2 drops 4-8 times a day.

    Side effects:

    Burning sensation, gluing of eyelids, allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    Not described.

    Special instructions:

    Patients who use contact vision correction, it is recommended to remove the lenses before using the drug and install them not earlier than 30 minutes after the application of drops.

    In the treatment it is not recommended to drive vehicles and work with moving mechanisms within 30 minutes after instillation of the drug.

    Instructions
    Up